Literature DB >> 12557251

Antiinvasive, antiangiogenic and antitumour activity of Ephedra sinica extract.

Nguyen-Hai Nam1, Chang-Woo Lee, Dong-Ho Hong, Hwan-Mook Kim, Ki-Hwan Bae, Byung-Zun Ahn.   

Abstract

A water fraction (EW), the remaining water phase from the methanol extract of Ephedra sinica after extraction with ethyl acetate and butanol, has been investigated for its antiangiogenic, antiinvasive and antitumour activities. It was observed that EW, at 30 micro g/mL, a non-cytotoxic concentration, inhibited the tube formation induced by human umbilical venous endothelial cells and the invasion of B16F10 melanoma cells through a matrix membrane by more than 90%. At 30 mg/kg/day, the inhibitory activity of EW on the growth of a tumour mass in BDF1 mice inoculated with B16-F10 murine melanoma cells was comparable to that of adriamycin (ADR) administered at 2 mg/kg/day. From these results, it could be postulated that the antitumour activity of the water fraction might be attributed to its antiangiogenic and antiinvasive activities. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12557251     DOI: 10.1002/ptr.901

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Comparative Pharmacokinetics and Bioavailability of Three Ephedrines in Rat after Oral Administration of Unprocessed and Honey-Fried Ephedra Extract by Response Surface Experimental Design.

Authors:  Yezhe Cheng; Yu Zhang; Hang Xing; Kun Qian; Longshan Zhao; Xiaohui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-19       Impact factor: 2.629

2.  Characterization of Proanthocyanidin Oligomers of Ephedra sinica.

Authors:  Joanna Orejola; Yosuke Matsuo; Yoshinori Saito; Takashi Tanaka
Journal:  Molecules       Date:  2017-08-06       Impact factor: 4.411

3.  Development of novel EST-SSR markers for Ephedra sinica (Ephedraceae) by transcriptome database mining.

Authors:  Si-Qian Jiao; Yan-Qiang Sun; Dong-Xu Zhang; Qiong Gao; Yuqing Jin; Hui Liu; Yongpeng Ma; Yong Yang; Ilga Porth; Jian-Feng Mao
Journal:  Appl Plant Sci       Date:  2019-01-16       Impact factor: 1.936

4.  A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo.

Authors:  Fairouz Sioud; Souheila Amor; Imène Ben Toumia; Aida Lahmar; Virginie Aires; Leila Chekir-Ghedira; Dominique Delmas
Journal:  Cells       Date:  2020-02-04       Impact factor: 6.600

5.  Ethnopharmacological Survey of Herbal Remedies Used for the Treatment of Cancer in the Greater Casablanca-Morocco.

Authors:  Mohammed Bourhia; Abdelaaty Abdelaziz Shahat; Omer Mohammed Almarfadi; Fahd Ali Naser; Wael Mostafa Abdelmageed; Amal Ait Haj Said; Fatiha El Gueddari; Abderrahim Naamane; Laila Benbacer; Naima Khlil
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-21       Impact factor: 2.629

6.  Oyaksungisan, a Traditional Herbal Formula, Inhibits Cell Proliferation by Induction of Autophagy via JNK Activation in Human Colon Cancer Cells.

Authors:  Nam-Hui Yim; Young Pil Jung; Aeyung Kim; Choong Je Ma; Won-Kyung Cho; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

7.  Fermented So-Cheong-Ryong-Tang (FCY) induces apoptosis via the activation of caspases and the regulation of MAPK signaling pathways in cancer cells.

Authors:  Nam-Hui Yim; Aeyung Kim; Young Pil Jung; Taesoo Kim; Choong Je Ma; Jin Yeul Ma
Journal:  BMC Complement Altern Med       Date:  2015-09-24       Impact factor: 3.659

Review 8.  Applicability of Plant Extracts in Preclinical Studies of Melanoma: A Systematic Review.

Authors:  Kamylla Rafaella Sena Albuquerque; Nívea Maria Pacheco; Thalia Del Rosario Loyo Casao; Fabiana Cristina Silveira Alves de Melo; Rômulo Dias Novaes; Reggiani Vilela Gonçalves
Journal:  Mediators Inflamm       Date:  2018-07-26       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.